This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Arul Mozhi Subbiah Karuppiah: Innovator in Pharmaceutical Chemistry
Introduction
Arul Mozhi Subbiah Karuppiah is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzyme activities. His work is characterized by a focus on innovative solutions for medical challenges.
Latest Patents
Arul holds a patent for "Heterocyclic PAD4 inhibitors," which involves substituted heterocyclic compounds of Formula (Ia). This patent outlines methods for preparing these compounds, pharmaceutical compositions that include them, and their use in treating diseases associated with PAD4 enzyme activity. His innovative approach aims to provide new therapeutic options for patients.
Career Highlights
Arul has established a successful career at Bristol-Myers Squibb Company, where he applies his expertise in drug development. His work has been instrumental in advancing the understanding of PAD4 inhibitors and their potential applications in medicine.
Collaborations
Throughout his career, Arul has collaborated with talented professionals, including Kumaravel Selvakumar and Venkatram Reddy Paidi. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Arul Mozhi Subbiah Karuppiah is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of diseases linked to PAD4 enzyme activity. His contributions reflect a commitment to advancing medical science through innovative research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
